BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3130152)

  • 1. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat.
    Sladek CD; Devine MA; Felten SY; Aravich PF; Blair ML
    Brain Res; 1988 Mar; 445(1):39-46. PubMed ID: 3130152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of naloxone on the release of neurohypophysial hormones in normotensive and spontaneously hypertensive rats.
    Rosella-Dampman LM; Emmert SE; Keil LC; Summy-Long JY
    Brain Res; 1985 Jan; 325(1-2):205-14. PubMed ID: 3978414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic stimulation of vasopressin release in spontaneously hypertensive rats.
    Sladek CD; Blair ML
    Hypertension; 1984; 6(6 Pt 1):855-60. PubMed ID: 6519742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and renin response to plasma volume loss in spontaneously hypertensive rats.
    Sladek CD; Blair ML; Chen YH; Rockhold RW
    Am J Physiol; 1986 Mar; 250(3 Pt 2):H443-52. PubMed ID: 3513627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of vasopressin-neurophysin and norepinephrine in the supraoptic nucleus of spontaneously hypertensive rats.
    Sladek JR; Davis BJ; Sladek CD
    Brain Res; 1986 Feb; 365(2):293-304. PubMed ID: 3512038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of captopril on converting enzyme activity in chemically sympathectomized, spontaneously hypertensive rats.
    Sattar MA; Latiff A; Gan EK
    Jpn J Pharmacol; 1985 Nov; 39(3):291-7. PubMed ID: 3005728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in vasopressin mechanisms in captopril-treated spontaneously hypertensive rats.
    Berecek KH; Wyss JM; Swords BH
    Clin Exp Hypertens A; 1991; 13(5):1019-31. PubMed ID: 1773493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4.
    Katayama S; Inaba M; Maruno Y; Morita T; Awata T; Oka Y
    Hypertens Res; 1997 Dec; 20(4):279-86. PubMed ID: 9453263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: independence from hypertension and renal hemodynamic effects of angiotensin.
    Jackson EK; Herzer WA; Mi Z; Vyas SJ; Kost CK
    J Pharmacol Exp Ther; 1999 Oct; 291(1):115-23. PubMed ID: 10490894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
    Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central depletion of catecholamines--importance of hypertension and anesthesia.
    Woodside JR; Beckman JJ; Althaus JS; Miller ED
    Anesth Analg; 1984 May; 63(5):482-8. PubMed ID: 6424508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and oxytocin gene expression in the supraoptic and paraventricular nucleus of the spontaneously hypertensive rat (SHR) during development of hypertension.
    van Tol HH; van den Buuse M; de Jong W; Burbach JP
    Brain Res; 1988 Dec; 464(4):303-11. PubMed ID: 3233490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Central norepinephrine and angiotensin II contents in the brain regions of spontaneously hypertensive rats (SHR) and the interaction between them].
    Yang K; Ding H; Zhou Q; Luo HY; Wu ZY
    Sheng Li Xue Bao; 1991 Aug; 43(4):345-51. PubMed ID: 1754901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal nociceptive transmission in the spontaneously hypertensive and Wistar-Kyoto normotensive rat.
    Randich A; Robertson JD
    Pain; 1994 Aug; 58(2):169-183. PubMed ID: 7816485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect.
    Stier CT; Chander P; Gutstein WH; Levine S; Itskovitz HD
    Am J Hypertens; 1991 Aug; 4(8):680-7. PubMed ID: 1930850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
    Mukherjee D; Sen S
    J Mol Cell Cardiol; 1993 Feb; 25(2):185-96. PubMed ID: 8474126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane potential of vascular smooth muscle and hypertension in spontaneously hypertensive rats.
    Cheung DW
    Can J Physiol Pharmacol; 1984 Aug; 62(8):957-60. PubMed ID: 6386129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term oral captopril treatment on mesenteric blood flow in spontaneously hypertensive rats.
    Rozsa Z; Sonkodi S
    Pharmacol Res; 1995; 32(1-2):21-5. PubMed ID: 8668643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.
    Limas C; Westrum B; Limas CJ
    Am J Pathol; 1984 Dec; 117(3):360-71. PubMed ID: 6391187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
    Wu JN; Tsai SY; Hsieh WY
    Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.